bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Cytokinetics logo

    Cytokinetics

    CYTK | NASDAQ
    Chart Builder DCF Calculator
    $67.89
    -$0.89 (-1.29%)
    Sep 21, 2026, 11:10 AM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $8.56B
    Enterprise Value
    $8.66B
    Beta
    0.36
    Average Volume
    2.39M
    Shares Outstanding (Diluted)
    132.09M
    Shares Change YoY
    10.57%
    Institutional Ownership
    N/A
    Exchange
    NASDAQ
    ISIN
    US23282W6057

    Price Performance

    Price Change 1M
    -10.2%
    Price Change 3M
    -13.1%
    Price Change 6M
    12.8%
    Price Change YTD
    11.4%
    Price Change 1Y
    39.5%
    Price Change 3Y
    122.2%
    Price Change 5Y
    107.6%
    1M CAGR (ann.)
    -15.5%
    1Y CAGR (ann.)
    44.6%
    5Y CAGR (ann.)
    18.4%
    All-Time CAGR
    2.3%

    Valuation

    PE Ratio
    -9.53
    Forward PE
    N/A
    PEG Ratio
    0.29
    Forward PEG
    0.37
    PS Ratio
    120.61
    Forward PS
    20.10
    PB Ratio
    -49.33
    P/FCF Ratio
    -11.69
    P/Adj. FCF Ratio
    -9.96
    P/OCF Ratio
    -16.34
    EV/Sales
    122.09
    EV/EBIT
    -10.38
    EV/EBITDA
    -10.58
    EV/FCF
    -11.83
    Earnings Yield
    -10.5%
    FCF Yield
    -8.6%
    Adj. FCF Yield
    -10.0%

    Financial Health

    Net Cash
    $18.6M
    Total Debt
    $1.27B
    Cash & Short-Term Investments
    $1.17B
    Total Assets
    $1.92B
    Current Ratio
    6.66
    Quick Ratio
    6.66
    Debt / Equity Ratio
    -7.32
    Debt / EBITDA
    -1.55
    Debt / FCF
    -1.74
    OCF / Debt
    -0.55
    Interest Coverage
    -5.64
    Altman Z-Score
    -1.14
    Piotroski F-Score
    3

    Margins & Profitability

    Gross Profit Margin
    85.0%
    Operating Profit Margin
    -993.0%
    EBITDA Margin
    -1153.6%
    Net Profit Margin
    -1259.9%
    FCF Margin
    -1031.7%
    Adj. FCF Margin
    -1211.0%
    SBC / Revenue
    136.4%
    SBC Impact (per share)
    -17.4%

    Returns

    Return on Assets
    -46.5%
    Return on Equity
    164.0%
    Return on Invested Capital
    -39.3%
    Return on Capital Employed
    -40.4%
    Return on Tangible Assets
    -46.5%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    92.5%
    Revenue CAGR 5Y
    4.2%
    Revenue CAGR 10Y
    8.3%
    EPS CAGR 3Y
    -15.7%
    EPS CAGR 5Y
    -14.9%
    EPS CAGR 10Y
    -18.5%
    FCF CAGR 3Y
    -31.7%
    FCF CAGR 5Y
    -22.3%
    FCF CAGR 10Y
    -27.9%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    35
    EPS Growth Next 3Y
    36.3%
    Revenue Growth Next 3Y
    176.9%
    Earnings Date
    N/A
    EPS Estimate (next Q)
    N/A
    EPS Growth Est (next Q)
    N/A
    Revenue Est (next Q)
    N/A
    Revenue Growth Est (next Q)
    N/A

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $112.50
    Price Target Upside
    63.6%

    Cash Flow

    Operating Cash Flow
    $-700.91M
    Free Cash Flow
    $-732.1M
    Adj. Free Cash Flow
    $-859.3M
    FCF Per Share
    -$4.40
    OCF Per Share
    -$4.21
    OCF/S Ratio
    -782.8%

    Income Statement

    Revenue
    $70.96M
    Gross Profit
    $60.3M
    Operating Income
    $-704.62M
    EBITDA
    $-818.6M
    Net Income
    $-894M
    EPS (Diluted)
    -$7.22
    Revenue / Employee
    $105.44K
    Profit / Employee
    $-1.33M
    Employees
    673

    © 2026 bestshares.com. All rights reserved.